Finance

Beta
Lists
AXGN:NASDAQ
AxoGen, Inc Common Stock
၄၄.၉၃ US$
+၀.၉၉%
(+၀.၄၄) 1D
၄၄.၉၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: ဇွန် ၂၆, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AXGN...
Open
၄၄.၄၁ US$
High
၄၅.၁၉ US$
Low
၄၃.၅၂ US$
Mkt. cap
၂၃၈.၉၃ ဋေ
Avg. vol.
၁.၁၄ သန်း
Volume
၃.၂၈ သန်း
52-wk high
၄၆.၀၀ US$
52-wk low
၁၀.၂၀ US$
EPS
-၀.၆၄ US$
Beta
၁.၁၂
Shares outstanding
၅.၃၂ ကုဋေ
No. of employees
၆၂၂
Open
၄၄.၄၁ US$
High
၄၅.၁၉ US$
Low
၄၃.၅၂ US$
Mkt. cap
၂၃၈.၉၃ ဋေ
Avg. vol.
၁.၁၄ သန်း
Volume
၃.၂၈ သန်း
52-wk high
၄၆.၀၀ US$
52-wk low
၁၀.၂၀ US$
EPS
-၀.၆၄ US$
Beta
၁.၁၂
Shares outstanding
၅.၃၂ ကုဋေ
No. of employees
၆၂၂
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Stock market today: S&P 500, Nasdaq, Dow futures climb as a halt to US-Iranian attacks is called
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
The Bull Case For Verizon (VZ) Could Change Following Dow Exit And Rising Starlink Competition
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၁ နာရီ
US Futures Climb on Reports Peace Talks to Resume: Markets Wrap
Business Insider
Business Insider
·
ပြီးခဲ့သည့် ၁၄ နာရီ
BofA warns the S&P 500 is flashing technical signals that a 'three-wave' stock correction is underway
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees၆၂၂
Founded၂၀၀၂
HeadquartersAlachua, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteaxogeninc.com
Analyst ratings
Based on 7 analysts giving stock ratings to AXGN in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AXGN in the last 3 months.
Highest
Current ၄၄.၉၃ US$
၅၅.၀၀ US$ (+၂၂.၄၁%)
Average
၅၀.၁၄ US$ (+၁၁.၆၀%)
Lowest
၄၈.၀၀ US$ (+၆.၈၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
၅၀.၀၀ US$
+၁၁.၃%
05/04/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
၅၅.၀၀ US$
+၂၂.၄%
04/29/2026
Jayson Bedford
Raymond James
Buy
Maintained
၄၈.၀၀ US$
+၆.၈%
04/29/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
၄၈.၀၀ US$
+၆.၈%
04/29/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
၅၀.၀၀ US$
+၁၁.၃%
04/29/2026
David Turkaly
Citizens JMP
Buy
Maintained
၅၀.၀၀ US$
+၁၁.၃%
04/29/2026
Frank Takkinen
Lake Street
Buy
Reiterated
၅၀.၀၀ US$
+၁၁.၃%
04/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၅.၆၇ ကုဋေ
၆.၀၁ ကုဋေ
၅.၉၉ ကုဋေ
၆.၁၅ ကုဋေ
Cost of goods sold
၁.၄၆ ကုဋေ
၁.၄၁ ကုဋေ
၁.၅၅ ကုဋေ
၁.၅၃ ကုဋေ
Cost of revenue
၁.၄၆ ကုဋေ
၁.၄၁ ကုဋေ
၁.၅၅ ကုဋေ
၁.၅၃ ကုဋေ
Research and development expenses
၆.၈၅ သန်း
၇.၅၆ သန်း
၁.၂၄ ကုဋေ
၇.၅၂ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၃၅ ကုဋေ
၃.၆၅ ကုဋေ
၄.၁၈ ကုဋေ
၄.၁၅ ကုဋေ
Operating expense
၄.၀၃ ကုဋေ
၄.၄၁ ကုဋေ
၅.၄၂ ကုဋေ
၄.၉၀ ကုဋေ
Total operating expenses
၅.၅၀ ကုဋေ
၅.၈၂ ကုဋေ
၆.၉၇ ကုဋေ
၆.၄၃ ကုဋေ
Operating income
၁.၆၇ သန်း
၁.၉၁ သန်း
-၉.၇၇ သန်း
-၂.၈၃ သန်း
Other non operating income
၆.၅၉ သိန်း
၂.၃၄ သိန်း
-၂.၀၂ သန်း
၂.၃၀ သောင်း
EBT including unusual items
၅.၇၉ သိန်း
၇.၀၈ သိန်း
-၁.၃၂ ကုဋေ
-၁.၉၆ ကုဋေ
EBT excluding unusual items
၅.၇၉ သိန်း
၇.၀၈ သိန်း
-၁.၃၂ ကုဋေ
-၂.၇၄ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
၅.၇၉ သိန်း
၇.၀၈ သိန်း
-၁.၃၂ ကုဋေ
-၁.၉၆ ကုဋေ
Net profit margin
၁.၀၂%
၁.၁၈%
-၂၁.၉၆%
-၃၁.၈၇%
Earnings per share
၀.၁၂
၀.၁၂
၀.၀၇
၀.၀၇
Interest and investment income
၂.၂၅ သိန်း
၃.၁၉ သိန်း
၃.၅၂ သိန်း
၇.၆၈ သိန်း
Interest expense
-၁.၉၈ သန်း
-၁.၇၆ သန်း
-၁.၇၂ သန်း
-၆.၉၄ သိန်း
Net interest expenses
-၁.၇၅ သန်း
-၁.၄၄ သန်း
-၁.၃၇ သန်း
၇.၄၀ သောင်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၃.၄၀ သန်း
၃.၆၄ သန်း
-၈.၀၄ သန်း
-၁.၁၃ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AXGN
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer